These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 15857248)
1. Epigenetic hypothesis tests for methylation and acetylation in a triple microarray system. Li L; Shi H; Yiannoutsos C; Huang TH; Nephew KP J Comput Biol; 2005 Apr; 12(3):370-90. PubMed ID: 15857248 [TBL] [Abstract][Full Text] [Related]
2. Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. Shi H; Wei SH; Leu YW; Rahmatpanah F; Liu JC; Yan PS; Nephew KP; Huang TH Cancer Res; 2003 May; 63(9):2164-71. PubMed ID: 12727835 [TBL] [Abstract][Full Text] [Related]
3. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. Dannenberg LO; Chen HJ; Tian H; Edenberg HJ Alcohol Clin Exp Res; 2006 Jun; 30(6):928-37. PubMed ID: 16737450 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Ou JN; Torrisani J; Unterberger A; Provençal N; Shikimi K; Karimi M; Ekström TJ; Szyf M Biochem Pharmacol; 2007 May; 73(9):1297-307. PubMed ID: 17276411 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
9. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Lee SH; Kim J; Kim WH; Lee YM Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007 [TBL] [Abstract][Full Text] [Related]
10. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines. Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic control of ovarian function: the emerging role of histone modifications. LaVoie HA Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412 [TBL] [Abstract][Full Text] [Related]
12. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts. Gozzini A; Santini V Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Vincent A; Perrais M; Desseyn JL; Aubert JP; Pigny P; Van Seuningen I Oncogene; 2007 Oct; 26(45):6566-76. PubMed ID: 17471237 [TBL] [Abstract][Full Text] [Related]
14. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Vaissière T; Sawan C; Herceg Z Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786 [TBL] [Abstract][Full Text] [Related]
16. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529 [TBL] [Abstract][Full Text] [Related]
17. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region. Al-Nakhle H; Smith L; Bell SM; Burns PA; Cummings M; Hanby AM; Lane S; Parker MD; Hughes TA; Speirs V Int J Oncol; 2013 Dec; 43(6):2039-45. PubMed ID: 24068253 [TBL] [Abstract][Full Text] [Related]
18. Histone deacetylation directs DNA methylation in survivin gene silencing. Ma AN; Lu J; Zhou XJ; Wang YX Biochem Biophys Res Commun; 2011 Jan; 404(1):268-72. PubMed ID: 21130077 [TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation. Krieger S; Grunau C; Sabbah M; Sola B Exp Hematol; 2005 Jun; 33(6):652-9. PubMed ID: 15911089 [TBL] [Abstract][Full Text] [Related]
20. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. Grassi G; Maccaroni P; Meyer R; Kaiser H; D'Ambrosio E; Pascale E; Grassi M; Kuhn A; Di Nardo P; Kandolf R; Küpper JH Carcinogenesis; 2003 Oct; 24(10):1625-35. PubMed ID: 12869421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]